On October 31, 2024, we will be updating our current Terms of Use and Privacy Notice. By continuing to use our products and service on October 31, 2024, you are agreeing to our updated Terms of Use and are acknowledging our updated Privacy Notice.
Harsimran Singh PhD,* Michelle Manning MA,* Haidee Sanchez BSc,* Keaton Stoner BS†, Stephanie Habif EdD MS*
To examine sleep related implications of new-age diabetes management devices including Basal-IQ technology in people with T1D and T2D.
We analyzed perceived quality of sleep and device-related satisfaction in participants from a diabetes research company’s (dQ&A) 2019 US-based panel.
Participants using the t:slim X2™ insulin pump with Basal-IQ® technology reported significantly better perceived quality of sleep and satisfaction with their insulin delivery device compared to participants using other insulin delivery devices.
Perceived quality of sleep was an important determinant of device-related satisfaction in this sample.